Veterans for Medical Cannabis Access

Last updated
Veterans for Medical Cannabis Access
Founded2007
Founder Martin H. Chilcutt
Type Non-profit organization
FocusProtecting basic human right to access required medicine
Location
Area served
United States
Key people
Michael Krawitz Al Byrne co-founders
Website veteransformedicalmarijuana.org

Veterans for Medical Cannabis Access (VMCA), which was founded as Veterans for Medical Marijuana Access (VMMA) reflecting the pejorative word "marijuana", is an Elliston, Virginia-based non-profit service organization designed to assist American veterans who wish to be able to use marijuana for medical purposes with a doctor's recommendation. VMCA works towards the freedom for veterans to discuss the medical use of marijuana with their doctors without the risk of reprisal.

Contents

Activity in the United States

When it was created in 2007, Veterans for Medical Cannabis Access was the first American veteran service organization designed to assist veterans with medical access to cannabis. Since then, VCMA has been lobbying and advocating both at the federal level (Veterans Affairs) and at the State-level, to geographically and qualitatively increase access to medical cannabis and derivates for US military veterans. The organization seeks to make sure that the United States federal government allows veterans access to medicines their doctor prescribes or recommends, and broaden the right to access and the affordability of medicines.

Activity at international level

Logo of the series of events organized in the United Nations Office at Vienna Logo Legal Regulations Fora 2017.png
Logo of the series of events organized in the United Nations Office at Vienna

During the first decade of the 21st century, VMCA increased its presence and advocacy close to the relevant international institutions, in particular on policy issues at the Commission on Narcotic Drugs meetings, and close to the United Nations Office on Drugs and Crime and the International Narcotics Control Board. VMCA is also following the process of scientific review of cannabis by the World Health Organization towards a change in the scheduling of the substance at international level. VCMA has developed close collaborations with major European NGOs such as DrugScience, the European Coalition for Just and Effective Drug Policies or the FAAAT think & do tank. VCMA Executive Director Michael Krawitz has been named Senior Adviser of FAAAT, with which he has developed an active advocacy and research in relation with the WHO review of Cannabis for international scheduling. [1] [2] In 2015 in Prague, VMCA was involved in the creation of the IMCPC (International Medical Cannabis Patients' Coalition). Since 2017, VCMA collaborates in the United Nations Office in Vienna to the organization of the Legal Regulations Fora, series of civil society events aimed at spreading ground-up proposals that aim to impact national decision-makers gathered in these meetings.

See also

Related Research Articles

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the category reserved for drugs that have "no currently accepted medical use", is a proposed legal and administrative change in cannabis-related law at the federal level. After being proposed repeatedly since 1972, the U.S. Department of Justice initiated 2024 rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act. The majority of 2024 public comments supported descheduling, decriminalizing, or legalizing marijuana at the federal level.

<span class="mw-page-title-main">Single Convention on Narcotic Drugs</span> 1961 international treaty regulating narcotic drugs

The Single Convention on Narcotic Drugs, 1961 is a United Nations treaty that controls activities of specific narcotic drugs and lays down a system of regulations for their medical and scientific uses; it also establishes the International Narcotics Control Board.

The International Narcotics Control Board (INCB) is an independent treaty body, one of the four treaty-mandated bodies under international drug control law.

<span class="mw-page-title-main">United Nations Commission on Narcotic Drugs</span> Central drug policy-making body of the UN System

The Commission on Narcotic Drugs (CND) is one of the functional commissions of the United Nations' Economic and Social Council (ECOSOC), and is the central drug policy-making body within the United Nations System. The CND also has important mandates under the three international drug control conventions, alongside the three other treaty-mandated bodies: United Nations Office on Drugs and Crime, World Health Organization, and International Narcotics Control Board.

A drug policy is the policy regarding the control and regulation of psychoactive substances, particularly those that are addictive or cause physical and mental dependence. While drug policies are generally implemented by governments, entities at all levels may have specific policies related to drugs.

<span class="mw-page-title-main">Cannabis Social Club</span> Non-profit industry model for recreational cannabis

A Cannabis Social Club (CSC), sometimes called Cannabis Club, Cannabis Association, or Teapad, is a type of cannabis retail outlet, an industry model for regulated cannabis organised as non-profit cooperatives in which cannabis is cultivated, shared, and enjoyed collectively, usually for the purpose of relaxing or for social communion.

<span class="mw-page-title-main">International Office of Public Hygiene</span> Predecessor to the World Health Organization

The International Office of Public Hygiene (OIPH), also known by its French name as the Office International d'Hygiène Publique (OIHP), was an international organization founded 9 December 1907 and based in Paris, France. It merged into the World Health Organization in 1946.

<span class="mw-page-title-main">Dronabinol</span> Generic name of Δ9-THC in medicine

Dronabinol, sold under the brand names Marinol and Syndros, is the generic name for the molecule of (−)-trans-Δ9-tetrahydrocannabinol (THC) in the pharmaceutical context. It has indications as an appetite stimulant, antiemetic, and sleep apnea reliever and is approved by the U.S. Food and Drug Administration (FDA) as safe and effective for HIV/AIDS-induced anorexia and chemotherapy-induced nausea and vomiting.

The list includes and details significant events that occurred in the global history of national-level implementations of, or changes made to, laws surrounding the use, sale, or production of the psychoactive drug cannabis.

<span class="mw-page-title-main">NORML France</span> French cannabis reform and harm reduction non-profit

NORML France, previously known as Chanvre & Libertés - NORML France is a French non-profit organization based in Toulouse but active in all territories of France, whose aim is to move public opinion sufficiently to achieve the depenalization of illicit drugs consumption, the legalization of non-medical marijuana and the increased access to medical cannabis in France, so that the responsible use of cannabis by adults is no longer subject to penalty.

<span class="mw-page-title-main">History of cannabis</span>

The history of cannabis and its usage by humans dates back to at least the third millennium BC in written history, and possibly as far back as the Pre-Pottery Neolithic B based on archaeological evidence. For millennia, the plant has been valued for its use for fiber and rope, as food and medicine, and for its psychoactive properties for religious and recreational use.

The status of Cannabis in international law refers to the series of dispositions in international law affecting States' sovereignty in relation to the Cannabis plant genus, to a variety of "cannabis products" derived from the plant, or to their synthetic analogs.

<span class="mw-page-title-main">Camille Barrère</span> French diplomat

Camille Barrère was a French diplomat, most notably the ambassador to Italy from 1897 to 1924.

<span class="mw-page-title-main">FAAAT think & do tank</span> Global think tank on drug policy reform

For Alternative Approaches to Addiction, Think & do tank is an international non-profit organization working on drug policy, created in 2015 and based in Paris, France.

<span class="mw-page-title-main">Michael Krawitz</span> US Air force veteran

Michael Alan Krawitz is a US Air force veteran, Executive Director of the non-profit Veterans for Medical Cannabis Access, researcher on the history of medical cannabis, and international advocate for cannabis policy reform with FAAAT think & do tank and the International Association for Cannabinoid Medicines.

The removal of cannabis and cannabis resin from Schedule IV of the Single Convention on narcotic drugs, 1961 is a change in international law that took place from 2019 to 2021, on the basis of a scientific assessment by the World Health Organization.

<span class="mw-page-title-main">Horizontal Working Party on Drugs</span> Body of the Council of the European Union

The Horizontal Working Party on Drugs is a Council Working Party, a preparatory body of the Council of the European Union established in 1997, responsible for the lead and management of the work of the council and of the European Union (EU) on drug policy.

Cannabis Sans Frontières is a Paris-based organization advocating for cannabis and drug policy reform. Founded in 2005 by Farid Ghehiouèche and Michel Sitbon, the organization aims to destigmatize cannabis usage and influence legislative change both in France and Europe. Known for its multifaceted approach to advocacy, Cannabis Sans Frontières combines political engagement, public education, and cultural impact to push for more progressive drug policies. With a focus on human rights and harm reduction, the organization has gained visibility through its various campaigns, participation in elections, and frequent media appearances.

The Berkeley Patients Group (BPG) is the oldest continuously operating cannabis dispensary in the United States, inaugurated in 1999 in Berkeley, California. BPG has been known not only for cannabis dispensation, but also for its involvement in advocacy campaigns for cannabis policy reforms and the rights of patients using marijuana for medical purposes, and for its involvement with the scientific community.

<span class="mw-page-title-main">Farid Ghehiouèche</span> French cannabis activist

Farid Ghehiouèche is a French author, activist and politician, known for his involvement for cannabis and other drugs liberalization, and in pacifist, ecologist, freedom of speech, gender equality, right of asylum and prison abolition social movements. He has been active since the 1990s in France and in international organizations.

References

  1. Susan Mayor (2019-02-05). "WHO proposes rescheduling cannabis to allow medical applications - BMJ: first published as 10.1136/bmj.l574 on 5 February 2019". BMJ (Clinical Research Ed.). 364. British Medical Journal: l574. doi:10.1136/bmj.l574. PMID   30723076. S2CID   73449383 . Retrieved 2019-02-06.
  2. Riboulet-Zemouli, Kenzi; Krawitz, Michael; Ghehiouèche, Farid (2021). History, science, and politics of international cannabis scheduling, 2015–2021. Vienna: FAAAT editions. ISBN   979-10-97087-50-0.